Oneness Biotech Co., Ltd. (LUX: ONEA)

Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
15.60
-0.90 (-5.45%)
At close: Nov 18, 2024
-52.15%
Market Cap 1.48B
Revenue (ttm) 3.17M
Net Income (ttm) -35.53M
Shares Out n/a
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close 16.50
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Oneness Biotech

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has co... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2008
Employees 43
Stock Exchange Luxembourg Stock Exchange
Ticker Symbol ONEA
Full Company Profile

Financial Performance

Financial numbers in TWD Financial Statements

News

There is no news available yet.